These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1392 related articles for article (PubMed ID: 11219392)

  • 21. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition.
    Pascual M; Nieto A; López-Nevot MA; Ramal L; Matarán L; Caballero A; Alonso A; Martín J; Zanelli E
    Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
    J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
    Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
    J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
    Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
    Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
    Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
    Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis.
    Taneja V
    Cytokine; 2015 Oct; 75(2):216-21. PubMed ID: 25541434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis.
    Park SH; Min DJ; Cho ML; Kim WU; Youn J; Park W; Cho CS; Kim HY
    Arthritis Rheum; 2001 Mar; 44(3):561-9. PubMed ID: 11263770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
    Bäcklund J; Carlsen S; Höger T; Holm B; Fugger L; Kihlberg J; Burkhardt H; Holmdahl R
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9960-5. PubMed ID: 12089323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis.
    Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS
    Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell proliferative response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis.
    Kim WU; Kim KJ
    J Rheumatol; 2005 Feb; 32(2):225-30. PubMed ID: 15693081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis.
    Taneja V; Behrens M; Basal E; Sparks J; Griffiths MM; Luthra H; David CS
    J Immunol; 2008 Aug; 181(4):2869-77. PubMed ID: 18684978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proliferation of type II collagen specific T cell response and antibody formation in rheumatoid arthritis and their relations to HLA-DR4].
    Zhou Q; Li X; Li R; Zheng WY; Li ZG
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):370-3. PubMed ID: 15854524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism.
    Taneja V; Griffiths MM; Luthra H; David CS
    Int Immunol; 1998 Oct; 10(10):1449-57. PubMed ID: 9796911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the "shared epitope" hypothesis may not apply.
    Teller K; Budhai L; Zhang M; Haramati N; Keiser HD; Davidson A
    J Rheumatol; 1996 Aug; 23(8):1363-8. PubMed ID: 8856614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
    Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.